Truveta
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $70M
Investors
- 17
About Truveta
Truveta Inc. is a US-based technology firm specializing in healthcare data analytics, providing organizations with actionable insights derived from extensive electronic health records to improve patient outcomes. Founded in 2020 and headquartered in Washington, US, Truveta Inc. focuses on leveraging electronic health record data for healthcare analytics. The company was established by CEO Terry Myerson, CTO Jay Nanduri and CMO Ryan Ahern. and Regeneron Pharmaceuticals, Inc.65 bn. Truveta's primary offerings center around its extensive electronic health record (EHR) data and analytics platform, aggregating data from over 120 million patients, including clinical notes, images, and linked closed claims from 200 million patients. This platform enables healthcare organizations to derive actionable insights on medical devices and disease states, addressing disparities in healthcare access. Truveta's solutions support life sciences, healthcare research, and public health sectors, enhancing drug discovery, optimizing clinical trials, and improving disease prevention and diagnosis. The company serves a diverse client base, including major health systems, pharmaceutical companies, and public health organizations, primarily in the US, with goals for global expansion. Truveta operates on a subscription-based revenue model, granting clients access to regulatory-grade EHR data and analytics tools. Clients, including healthcare organizations and life science entities, utilize Truveta's comprehensive data for safety evaluations, health economics and outcomes research (HEOR), and clinical trial support. Collaborations with healthcare providers facilitate continuous data exchange, enhancing insights and analytics. Pricing structures for services are tailored to the needs of individual clients. Key products such as the Truveta Language Model and Truveta Studio are integral to supporting stakeholders in improving patient care and healthcare delivery. In January 2025, Truveta Inc. The company aims to expand its offerings and enhance its platform capabilities. Future initiatives include targeting new geographic markets to broaden its client base and further develop its data analytics services.
Who invested in Truveta
17 investors across 1 round
See all investors in Truveta
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 13, 2021
Amount
$70M
Investors
Questions about Truveta
Who invested in Truveta?
Truveta has 17 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Truveta raised?
Truveta has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Truveta last raise money?
Truveta's most recent round on record is a Series A, in Jul 2021.
What does Truveta do?
Truveta is a healthcare it company.
Where is Truveta headquartered?
Truveta is headquartered in Bellevue, US.
Which VCs invest in companies like Truveta?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Truveta's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Truveta? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.